Dr. Reddy’s secures early win in Novo Nordisk’s ‘Ozempic’ infringement claim
On May 29, the Delhi High Court recorded Dr. Reddy’s undertaking not to sell its Ozempic-like drug in India, amid Novo Nordisk’s ongoing patent suit. Dr. Reddy’s noted it holds a manufacturing licence but reserves the right to export to non-patent jurisdictions—an argument opposed by Novo...
Dr. Reddy’s secures early win in Novo Nordisk’s ‘Ozempic’ infringement claim
Managing IP has covered the ongoing patent dispute between Novo Nordisk (represented by K&S Partners) and Dr. Reddy’s over semaglutide (Ozempic). While the Delhi High Court has declined interim relief at this stage, the case is still in its early phases and will continue to be heard in...
Asserting Patent Infringement with the help of Doctrine of Equivalence
The overarching issue in SNPC Machines Private Limited & Ors. v. Mr. Vishal Choudhary revolves around the application of the doctrine of equivalents to determine patent infringement, focusing on whether functional similarities between two competing brick-making machines constitute a violation of patent rights, despite differences in their...
Asserting Patent Infringement with the help of Doctrine of Equivalence
The overarching issue in SNPC Machines Private Limited & Ors. v. Mr. Vishal Choudhary revolves around the application of the doctrine of equivalents to determine patent infringement, focusing on whether functional similarities between two competing brick-making machines constitute a violation of patent rights, despite differences in their...
Disobeying interim injunction seen as Contempt of Court
In the case, Pfizer Inc & Ors. v Triveni Interchem Private Limited & Ors, the Delhi High Court (Court) came down heavily on Triveni Interchem Private Limited and Triveni Chemicals (together referred as Triveni) after Triveni was found guilty of “wilful” and “contumacious” contempt of the Court for disobeying an...